Korro Bio, Inc.$20.22 %
Analyst Rating: Hold
Stock Details
CEO
Ram Aiyar MBA,
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
112
Address
One Kendall Square, Cambridge, MA, 02139-1562
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Korro Bio, Inc. $20.22
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results